StockWatch
·
Pharmaceuticals
Quarterly Result5 Nov 2026, 06:54 pm

Abbott India declares Unaudited Q2 FY27 Financial Results

AI Summary

Abbott India Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results along with the Limited Review Report from statutory auditors Walker Chandiok & Co. LLP. The company operates in a single segment: Pharmaceuticals. The board meeting commenced at 4:00 pm and concluded at 6:30 pm on November 5, 2026.

Key Highlights

  • Unaudited financial results for Q2 FY27 declared.
  • Limited Review Report obtained from statutory auditors.
  • Company operates solely in the Pharmaceuticals segment.
  • Board meeting held on November 5, 2026, approved the results.